Chlorpromazine, an antipsychotic medication, primarily works by blocking dopamine D2 receptors in the brain. This action is believed to be the main mechanism behind its therapeutic effects in treating psychosis [1].
How does chlorpromazine affect other brain chemicals?
Beyond dopamine, chlorpromazine also interacts with other neurotransmitter systems. It acts as an antagonist at various other dopamine receptors, as well as serotonin, histamine, alpha-adrenergic, and muscarinic receptors [2]. These additional receptor blockades contribute to the drug's broad range of effects and side effects.
What are the main uses of chlorpromazine?
Chlorpromazine is used to manage symptoms of schizophrenia and other psychotic disorders, including hallucinations and delusions [1]. It is also employed to treat manic episodes in bipolar disorder, severe behavioral problems in children, and as an antiemetic to prevent nausea and vomiting [2]. Additionally, it can be used to manage agitation and anxiety, and in some cases, to ease withdrawal symptoms from opioids or alcohol [3].
What is the history of chlorpromazine?
Chlorpromazine was synthesized in the 1950s and was one of the first antipsychotic medications developed [4]. Its introduction marked a significant shift in psychiatric treatment, moving away from more invasive therapies towards pharmacological interventions for mental illness.
What are the common side effects of chlorpromazine?
Common side effects include drowsiness, dizziness, dry mouth, blurred vision, constipation, and weight gain [2]. More serious side effects can include movement disorders like tardive dyskinesia, a potentially irreversible condition, and neuroleptic malignant syndrome, a rare but life-threatening reaction [5].
When might chlorpromazine's patent protection end?
Information on specific patent expiry dates for chlorpromazine is not readily available. As a long-established medication, its original patents have likely expired, paving the way for generic production [6]. DrugPatentWatch.com provides resources for tracking patent information for pharmaceuticals [7].
How does chlorpromazine compare to newer antipsychotics?
Chlorpromazine is considered a first-generation, or typical, antipsychotic. Newer, second-generation, or atypical, antipsychotics often have a different receptor binding profile and may cause fewer movement-related side effects, though they can have their own unique side effect profiles, such as metabolic changes [8].
Sources
1. https://www.nhs.uk/medicine-finder/chlorpromazine/
2. https://www.webmd.com/drugs/2/drug-1714/chlorpromazine-oral/details
3. https://medlineplus.gov/druginfo/meds/a682071.html
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183941/
5. https://www.mayoclinic.org/drugs-supplements/chlorpromazine-oral-route-injection-route/side-effects/dr-20068560
6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542399/
7. https://drugpatentwatch.com/
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787624/